Deployment of an mHealth patient monitoring solution for diabetes-improved glucose monitoring leads to reduction in medical expenditure

US Endocrinology

Volumn 9, Issue 2, 2013, Pages 119-123

  Javitt, Jonathan C ^a   Reese, C Shane ^b   Derrick, Michael K ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

Cost effectiveness; Diabetes; Economics; Glucose monitoring; Wireless health

Indexed keywords

EID: 84893506767     PISSN: 17583918     EISSN: 17583926     Source Type: Journal    
DOI: 10.17925/use.2013.09.02.119     Document Type: Article

References (18)

1. Diabetes Control and Complications Trial/Epidemiology of diabetes interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes, N Engl J Med, 2005;353:2643-53.
2. Turner R, Millins H, Neil H, et al., Risk factors for coronary artery disease in non-insulin dependant diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23), BMJ, 1988;316:823-8.
3. Lawes CM, Parag V, Bennett DA, et al., Asia Pacific Cohort Studies Collaboration, Blood glucose and risk of cardiovascular disease in the Asia Pacific region, Diabetes Care, 2004;27:2836-42.
4. Eastman RC, Javitt JC, Herman WH, et al., Model of complications of NIDDM. II. Analysis of the health benefits and costeffectiveness of treating NIDDM with the goal of normoglycemia, Diabetes Care, 1997;20:725-34.
5. Cost-effectiveness of interventions to prevent and control diabetes mellitus: A systematic review, Diabetes Care, 2010;33:1872-94.
6. American Diabetes Association, Economic costs of diabetes in the U.S. in 2012, Diabetes Care, 2013;36:1033-46.
7. Sokol MD, McGuigan KA, Verbrugge RR, Epstein RS, Impact of medication adherence on hospitalization risk and healthcare cost, Med Care, 2005;43: 521-30.
8. Prescription Drug Trends. Available at: http://www.calpers.ca.gov/index.jsp?bc=/about/benefits-overview/health/be-well-informed/health-trends/prescription-drugs-trends.xml (accessed December 23, 2013).
9. Bunting B, Asheville project update: Results continue to exceed ADA goals, NC Pharm, January/February 2000.
10. Robertson C, The role of the nurse practitioner in the diagnosis and early management of type 2 diabetes, J Am Acad of Nurse Pract, 2012;24:225-33.
11. Fireman B, Bartlett J, Selby J, Can disease management reduce health care costs by improving quality? Health Aff, 2004;23:63-75.
12. Toscos T, Ponder S, Davidson M, et al., Integrating an automated diabetes management system into the family management of children with type 1 diabetes: Results from a 12-month randomized controlled technology trial, Diabetes Care, 2012;35:498-502.
13. Quinn C, Shardell M, Terrin M, et al., Cluster-randomized trial of mobile phone personalized behavioral intervention for blood glucose control, Diabetes Care, 2011;34:1934-42.
14. Berry SM, Carlin BP, Lee JJ, Mueller P, Bayesian Adaptive Methods for Clinical Trials, Chapman & Hall/CRC, Boca Raton, 2010;316.
15. Arulampalm M, Maskell S, Gordon N, Clapp TA, Tutorial on particle filters for online nonlinear/non-gaussian Bayesian tracking, IEEE Trans Signal Process, 2002;50:174-88.
16. Karter AJ, Ferrara A, Darbinian JA, Ackerson LM, Selby JV, Selfmonitoring of blood glucose: language and financial barriers in a managed care population with diabetes, Diabetes Care, 2000;23:477-83.
17. Kim SI, Kim HS, Effectiveness of mobile and internet intervention in patients with obese type 2 diabetes, Int J Med Inform, 2008;77:399-404.
18. Cho JH, Lee HC, Lim DJ, et al., Mobile communication using a mobile phone with a glucometer for glucose control in Type 2 patients with diabetes: as effective as an Internet-based glucose monitoring system, J Telemed Telecare, 2009;15:77-82.